Abstract
Purpose The clustering of metabolic abnormalities may weaken vaccine-induced immunity, but epidemiological data regarding SARS-CoV-2 vaccines are scarce. The present study examined the cross-sectional association between metabolic syndrome (MetS) and humoral immune response to Pfizer–BioNTech vaccine among healthcare workers.
Methods Participants were 946 healthcare workers, aged 21–75 years, who had completed the second dose of Pfizer–BioNTech vaccine 1–3 months before the survey. MetS was defined according to the Joint Interim Statement. SARS-CoV-2 spike immunoglobulin G (IgG) antibody was measured using quantitative assays. Multivariable linear regression was used to estimate the geometric mean titers (GMT) and geometric mean ratio (GMR) of IgG titers, relative to MetS status.
Results A total of 51 participants (5.4%) had MetS. Healthcare workers with MetS had a significantly lower IgG titer (GMT 3882; 95% confidence interval [CI], 3124–4824) than those without MetS (GMT 5033; 95% CI, 4395–5764); the GMR was 0.77 (95% CI 0.64–0.93). The GMR for IgG titers among those having 0 (reference group), 1, 2, 3, or ≥ 4 MetS components was 1.00, 1.00, 0.89, 0.86 and 0.61, respectively (Ptrend = 0.004).
Conclusion Results suggest that having MetS and a greater number of its components are associated with a weaker humoral immune response to the Pfizer–BioNTech vaccine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the NCGM COVID-19 Gift Fund (grant number 19K059), and the Japan Health Research Promotion Bureau Research Fund (grant number 2020-B-09).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of National Center for Global Health and Medicine
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to ethical restrictions and participant confidentiality concerns.
Abbreviations1
- 1MetS
- metabolic syndrome
- Ig
- immunoglobulin
- GMT
- geometric mean titers
- GMR
- geometric mean ratio
- CI
- confidence interval
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus
- NCGM
- National Center for Global Health and Medicine
- FPG
- fasting plasma glucose
- BP
- blood pressure
- TG
- triglycerides
- HDL-C
- high-density lipoprotein cholesterol
